Concord Biotech Ltd. (CONCORDBIO): Concord Biotech Share Price Rises 5.88% Today

Concord Biotech Share Price rises 5.88% to Rs 1,328, marking a significant gain in the mid cap category.

Concord Biotech Share Price has seen a notable increase today, rising by 5.88% to reach Rs 1,328. This significant movement places the company in the spotlight within the mid cap category, where it has a market capitalisation of Rs 13,150.26 crore. The stock opened at Rs 1,265.1 and reached a high of Rs 1,330, demonstrating strong investor interest. The day's trading volume was substantial, with 140,732 shares changing hands, indicating heightened market activity.

< The company's performance today has attracted attention, although the specific catalyst behind this movement is not identified in the available data. Investors and analysts are keenly observing the stock's performance, given its significant gain in a single trading session.

Concord Biotech Ltd. (CONCORDBIO) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,328
Previous Close	Rs 1,254.2
Today's Change	+Rs 73.8 (+5.88%)
Day Open	Rs 1,265.1
Day High	Rs 1,330
Day Low	Rs 1,262.9
Current Volume (BSE)	8,934
BSE Traded Volume	8,934
NSE Traded Volume	1,31,798
Combined NSE + BSE Volume	1,40,732
Turnover	Rs 1.19 crore
Market Capitalisation	Rs 13,150.26 crore
Market Cap Category	Mid Cap

Concord Biotech Ltd. (CONCORDBIO) traded at Rs 1,328. versus the previous close of Rs 1,254.2, a rise of 5.88%. The stock opened at Rs 1,265.1, reached Rs 1,330, touched Rs 1,262.9. Reported volume was 8,934.

Concord Biotech Ltd. (CONCORDBIO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 13,150.26 crore

The healthcare sector benchmark, with a P/E median of 26.44 and an average of 87.62, provides a context for evaluating Concord Biotech's valuation. The sector's P/B median is 1.9, with an average of 2.55, indicating a range of valuations within the industry. Concord Biotech's performance in terms of ROE and ROCE, compared to sector averages of 15.18% and 17.64% respectively, will be key indicators of its financial health and operational efficiency.

Investors will be keen to assess Concord Biotech's growth prospects and profitability in relation to its peers in the healthcare sector. The company's ability to generate returns on equity and capital employed will be critical factors in sustaining investor interest.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.44x
Benchmark Average P/E	87.62x
Benchmark P/E Range	3.61x to 3,439.3x
Benchmark Median P/B	1.9x
Benchmark Median ROE	11.07%
Benchmark Median ROCE	13.24%
Company Market Capitalisation	Rs 13,150.26 crore
Benchmark Median Market Cap	Rs 140.64 crore

Concord Biotech Ltd. (CONCORDBIO) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Concord Biotech operates within the healthcare sector, which encompasses a wide range of companies with varying market capitalisations and financial metrics. The sector benchmark, consisting of 198 companies, provides a comprehensive overview of the industry's performance.

Within this sector, the P/E ratio ranges from a minimum of 3.61 to a maximum of 3439.3, with a median of 26.44. Concord Biotech's valuation will be compared against these benchmarks to assess its market positioning. The sector's P/B ratio ranges from -16.79 to 16.32, with a median of 1.9, highlighting the diversity in valuations.

The healthcare sector's median ROE is 11.07%, with an average of 15.18%, while the median ROCE is 13.24%, with an average of 17.64%. These metrics provide a framework for evaluating Concord Biotech's financial performance relative to its peers.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,921.65	29.31	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,815.27	39.89	8.12	28.21	26.35
Hikal Ltd.	HIKAL	2,738.51	0	2.23	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,653.99	0	3.04	0	5.36
Sai Parenteral's Ltd.	SAIPARENT	2,476.69	169.37	3.13	13.9	12.97

Concord Biotech Ltd. (CONCORDBIO) has a market capitalisation of Rs 13,150.26 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

In the healthcare sector, Concord Biotech competes with several peers, including Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd. These companies vary in market capitalisation and financial metrics, providing a diverse landscape for comparison.

Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,921.65 crore and a P/E of 29.31, while Kwality Pharmaceuticals Ltd. boasts a higher P/E of 39.89 and a market cap of Rs 2,815.27 crore. Hikal Ltd., with a market cap of Rs 2,738.51 crore, offers a P/B ratio of 2.23. These comparisons highlight the competitive environment in which Concord Biotech operates.

Why Investors Are Watching Concord Biotech

Concord Biotech's recent price rise has caught the attention of investors and analysts alike. The company's performance today, marked by a 5.88% increase in share price, positions it as a notable player in the healthcare sector.

• Significant price rise of 5.88% today.
• Strong trading volume and market interest.
• Operates in a competitive healthcare sector.
• Valuation metrics compared to sector benchmarks.

Investors will continue to monitor Concord Biotech's performance, focusing on its ability to sustain momentum and deliver financial results in line with sector expectations.

About Concord Biotech

Concord Biotech Ltd. is a prominent player in the healthcare sector, focusing on the development and manufacturing of biopharmaceutical products. The company operates within the pharmaceuticals and drugs industry, offering a range of products that cater to various medical needs.

With a strong emphasis on research and development, Concord Biotech aims to deliver innovative solutions that address critical healthcare challenges. The company's commitment to quality and sustainability has positioned it as a trusted partner in the healthcare industry.

Track Concord Biotech Share Price on Univest

Use Concord Biotech Ltd. (CONCORDBIO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors and market enthusiasts can track Concord Biotech Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share prices, technical indicators, fundamental ratios, and market trends, enabling users to make informed investment decisions.

Frequently Asked Questions

What is the current share price of Concord Biotech?

Ans. The current share price of Concord Biotech is Rs 1,328, reflecting a 5.88% increase from the previous close of Rs 1,254.2. The stock moved 5.88% during the session. The intraday range extended from Rs 1,262.9 to Rs 1,330.

How much did Concord Biotech's share price rise today?

Ans. Concord Biotech's share price rose by 5.88% today, marking a significant gain in the mid cap category. The stock moved 5.88% during the session. The intraday range extended from Rs 1,262.9 to Rs 1,330.

How does Concord Biotech's P/E ratio compare to the sector median?

Ans. 44, offering a benchmark for comparison. The relevant peer median P/E is 26.44x. The peer average P/E is 87.62x. The stock belongs to the Healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.

What is the sector benchmark for ROE in healthcare?

Ans. The sector benchmark for ROE in healthcare is a median of 11.07% and an average of 15.18%, providing a context for evaluating company performance. The relevant peer median ROE is 11.07%.

Who are Concord Biotech's main competitors?

Ans. Concord Biotech's main competitors include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd., among others in the healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.

How can I track Concord Biotech's share price?

Ans. You can track Concord Biotech's share price on Univest, which provides real-time updates, technical indicators, and market insights. The stock moved 5.88% during the session. The intraday range extended from Rs 1,262.9 to Rs 1,330.